中药ETF鹏华(159647)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
-48,117,656.95 |
-15,332,033.59 |
-19,259,468.95 |
-80,534,158.95 |
| 利息合计 |
172,676.45 |
93,255.55 |
1,126,728.62 |
832,139.58 |
| 其中:存款利息收入 |
172,676.45 |
93,255.55 |
317,811.29 |
168,918.12 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-2,136,384.82 |
-14,312,844.14 |
-43,385,126.87 |
-31,984,515.51 |
| 其中:股票投资收益 |
-23,231,013.87 |
-24,320,175.92 |
-63,901,034.31 |
-43,911,590.34 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
21,094,629.05 |
10,007,331.78 |
20,515,907.44 |
11,927,074.83 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-46,693,739.49 |
-1,482,207.74 |
22,007,771.48 |
-50,289,116.31 |
| 其他收入 |
539,790.91 |
369,762.74 |
991,157.82 |
907,333.29 |
| 费用 |
5,695,451.54 |
2,298,406.46 |
4,525,655.43 |
2,179,869.50 |
| 管理人报酬 |
4,458,792.97 |
1,781,075.89 |
3,498,202.79 |
1,662,902.36 |
| 基金托管费 |
891,758.57 |
356,215.23 |
699,640.43 |
332,580.35 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
344,900.00 |
161,115.34 |
324,900.00 |
181,999.02 |
| 利润总额 |
-53,813,108.49 |
-17,630,440.05 |
-23,785,124.38 |
-82,714,028.45 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年